WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced the appointment of Linda Nardone, Ph.D. to the newly created position of Chief Operating Officer and Executive Vice President. Dr. Nardone will report directly to Kenneth M. Borow, M.D., Encorium’s President and Chief Executive Officer, and will be based at the Company’s corporate headquarters in Wayne, PA.
